144 related articles for article (PubMed ID: 1403122)
21. [Meningeal gliomatosis--clinical features and results of treatment].
Arita N; Hayakawa T; Mogami H; Ushio Y
Gan No Rinsho; 1989 Sep; 35(11):1308-12. PubMed ID: 2478733
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
[TBL] [Abstract][Full Text] [Related]
24. Modification of tumor blood flow and enhancement of therapeutic effect of ACNU on experimental rat gliomas with angiotensin II.
Tokuda K; Abe H; Aida T; Sugimoto S; Kaneko S
J Neurooncol; 1990 Jun; 8(3):205-12. PubMed ID: 2358853
[TBL] [Abstract][Full Text] [Related]
25. Development of experimental meningeal gliomatosis models in rats.
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Arita N; Mogami H
J Neurosurg; 1986 Oct; 65(4):503-7. PubMed ID: 3760960
[TBL] [Abstract][Full Text] [Related]
26. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
[TBL] [Abstract][Full Text] [Related]
27. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
29. Effects of high-dose chemotherapy with syngeneic bone marrow transplantation in experimental brain tumor in rats.
Soma M; Shoin K; Yamashita J
Cancer; 1993 Jan; 71(2):364-9. PubMed ID: 8422630
[TBL] [Abstract][Full Text] [Related]
30. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
Kawai H; Toyohara J; Kado H; Nakagawa T; Takamatsu S; Furukawa T; Yonekura Y; Kubota T; Fujibayashi Y
Nucl Med Biol; 2006 Jan; 33(1):29-35. PubMed ID: 16459256
[TBL] [Abstract][Full Text] [Related]
31. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
32. [Meningeal gliomatosis: development of experimental models].
Yoshida T; Ushio Y; Hayakawa T; Arita N; Yamada K; Mogami H
No Shinkei Geka; 1984 Sep; 12(10):1141-8. PubMed ID: 6504251
[TBL] [Abstract][Full Text] [Related]
33. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
34. Hypersensitivity of rat glioma sublines with acquired ACNU resistance to L-asparaginase.
Saito Y; Nakada Y; Hotta T; Mikami T; Kurisu K; Kiya K; Kawamoto K; Uozumi T
J Neurosurg; 1991 Dec; 75(6):930-4. PubMed ID: 1682427
[TBL] [Abstract][Full Text] [Related]
35. [Experimental studies on induced hypertension chemotherapy of intracerebral inoculated gliomas in rats].
Tokuda K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):612-20. PubMed ID: 3463530
[TBL] [Abstract][Full Text] [Related]
36. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Levin VA; Chamberlain M; Silver P; Rodriguez L; Prados M
Cancer Chemother Pharmacol; 1989; 23(5):301-7. PubMed ID: 2706735
[TBL] [Abstract][Full Text] [Related]
38. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
[TBL] [Abstract][Full Text] [Related]
39. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
[TBL] [Abstract][Full Text] [Related]
40. Specific induction of ACNU-resistance in V79 Chinese hamster cells and C6 rat glioma cells.
Horie Y; Arai K; Endoh S; Kuroki T; Takaku A
J Neurosurg; 1987 Oct; 67(4):553-7. PubMed ID: 3477613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]